These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 16778711)

  • 21. The paradox of quetiapine in obsessive-compulsive disorder.
    Tranulis C; Potvin S; Gourgue M; Leblanc G; Mancini-Marie A; Stip E
    CNS Spectr; 2005 May; 10(5):356-61. PubMed ID: 15858452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole.
    Englisch S; Esslinger C; Inta D; Weinbrenner A; Peus V; Gutschalk A; Schirmbeck F; Zink M
    Clin Neuropharmacol; 2009; 32(4):227-9. PubMed ID: 19644230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obsessive-compulsive symptoms in adjunctive therapy with lamotrigine in clozapine-medicated patients.
    Szmulewicz AG; Valerio MP; Smith JM
    Schizophr Res; 2015 Aug; 166(1-3):364-5. PubMed ID: 26058675
    [No Abstract]   [Full Text] [Related]  

  • 24. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
    Hermida J; Paz E; Tutor JC
    Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clozapine-Associated Obsessive-Compulsive Symptoms and Their Management: A Systematic Review and Analysis of 107 Reported Cases.
    Kim DD; Barr AM; Lu C; Stewart SE; White RF; Honer WG; Procyshyn RM
    Psychother Psychosom; 2020; 89(3):151-160. PubMed ID: 32045914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obsessive-compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature.
    Ke CL; Yen CF; Chen CC; Yang SJ; Chung W; Yang MJ
    Kaohsiung J Med Sci; 2004 Jun; 20(6):295-301. PubMed ID: 15253471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clozapine-induced obsessive–compulsive symptoms: mechanisms and treatment.
    Kim DD; Barr AM; White RF; Honer WG; Procyshyn RM
    J Psychiatry Neurosci; 2019 Jan; 44(1):71-72. PubMed ID: 30565908
    [No Abstract]   [Full Text] [Related]  

  • 28. The improvement of obsessive- compulsive symptoms in a patient with schizophrenia treated with clozapine.
    Kumar S; Ng B; Howie W
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):235-6. PubMed ID: 12667173
    [No Abstract]   [Full Text] [Related]  

  • 29. Obsessive-compulsive symptoms during treatment with clozapine in a patient with schizophrenia.
    Cheung EF
    Aust N Z J Psychiatry; 2001 Oct; 35(5):695-6. PubMed ID: 11551293
    [No Abstract]   [Full Text] [Related]  

  • 30. Simultaneous determination of clozapine and its N-desmethyl and N-oxide metabolites in plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to plasma level monitoring in schizophrenic patients.
    Aravagiri M; Marder SR
    J Pharm Biomed Anal; 2001 Sep; 26(2):301-11. PubMed ID: 11470207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.
    González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H
    Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The usefulness of monitored therapy using Clozapine concentration in the blood serum for determining drug dose in Polish schizophrenic patients.
    Piwowarska J; Radziwoń-Zaleska M; Dmochowska M; Szepietowska E; Matsumoto H; Sygitowicz G; Pilc A; Łukaszkiewicz J
    Pharmacol Rep; 2016 Dec; 68(6):1120-1125. PubMed ID: 27588387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clozapine and obsessive-compulsive symptoms in schizophrenia. A case history of one patient].
    Bürgy M
    Nervenarzt; 1999 Jan; 70(1):64-7. PubMed ID: 10087519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders.
    de Haan L; Linszen DH; Gorsira R
    J Clin Psychiatry; 1999 Jun; 60(6):364-5. PubMed ID: 10401913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Schizophrenic with obsessive-compulsive disorder or symptoms].
    Doubremelle C; Millet B; Olie JP
    Encephale; 2000; 26(2):81-8. PubMed ID: 10858921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emergence of obsessive compulsive symptoms during treatment with clozapine.
    Baker RW; Chengappa KN; Baird JW; Steingard S; Christ MA; Schooler NR
    J Clin Psychiatry; 1992 Dec; 53(12):439-42. PubMed ID: 1487472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations.
    Llorca PM; Lancon C; Disdier B; Farisse J; Sapin C; Auquier P
    J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients.
    Perry PJ; Miller DD; Arndt SV; Cadoret RJ
    Am J Psychiatry; 1991 Feb; 148(2):231-5. PubMed ID: 1670979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical risk factors, phenomenology and the impact of clozapine induced obsessive compulsive symptoms.
    Gürcan G; Şenol ŞH; Yağcıoğlu AEA; Ertuğrul A
    Psychiatry Res; 2021 Feb; 296():113665. PubMed ID: 33465593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.